Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)

de Corso, E.; Pasquini, E.; Trimarchi, M.; La Mantia, I.; Pagella, F.; Ottaviano, G.; Garzaro, M.; Pipolo, C.; Torretta, S.; Seccia, V.; Cantone, Elena; Ciofalo, A.; Lucidi, D.; Fadda, G.; Pafundi, P.; Settimi, S.; Montuori, C.; Anastasi, F.; Pagliuca, G.; Ghidini, A.; Cavaliere, C.; Maffei, M.; Bussu, F.; Gallo, S.; Rikky Mauritz Canevari, Frank; Paludetti, G.; Galli, J.

doi:10.1111/all.15772

Public

Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)

Shared by NobleBlocks on May 18, 2023 • 12:00 AM UTC

Authors:

E. de Corso

E. Pasquini

M. Trimarchi

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and reduced health‐related quality of life. Findings from clinical trials have demonstrated the effectiveness of dupilumab in CRSwNP, although real‐world evidence is still limited.

Subject

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!